Presentation + Paper
16 March 2023 Digital holographic microscopy for label-free in vitro cytotoxicity testing of polymeric nanocarriers: an interlaboratory comparison
Author Affiliations +
Proceedings Volume 12389, Quantitative Phase Imaging IX; 123890F (2023) https://doi.org/10.1117/12.2649808
Event: SPIE BiOS, 2023, San Francisco, California, United States
Abstract
Digital holographic microscopy (DHM) has been demonstrated to be a suitable label-free and non-invasive quantitative phase imaging (QPI) tool in risk assessment of the cytotoxic potential of engineered nanoparticles and organic nanocarriers. For a broader application, robustness of DHM-based assays needs to be demonstrated towards DHM standardization in risk assessment. Thus, we performed an interlaboratory comparison on the transferability and reproducibility of a DHM-based assay. The cytotoxic potential of organic nanoparticles on A549 lung epithelial cells was analyzed in two European laboratories using identically constructed DHM systems. Our results demonstrate a solid and accurate performance of the DHM-based cytotoxicity assay
Conference Presentation
© (2023) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Anne Marzi, Kai Moritz Eder, Álvaro Barroso, Ane Marit Wågbø, Torkild Visnes, Ruth B. Schmid, Geir Klinkenberg, Björn Kemper, and Jürgen Schnekenburger "Digital holographic microscopy for label-free in vitro cytotoxicity testing of polymeric nanocarriers: an interlaboratory comparison", Proc. SPIE 12389, Quantitative Phase Imaging IX, 123890F (16 March 2023); https://doi.org/10.1117/12.2649808
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Laboratories

Control systems

Nanoparticles

Digital holography

In vitro testing

Particles

Polymers

Back to Top